These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 3083198)

  • 1. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.
    Cheng HM; González RG
    Metabolism; 1986 Apr; 35(4 Suppl 1):10-4. PubMed ID: 3083198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of an aldose reductase inhibitor (Sorbinil) on the level of metabolites in lenses of diabetic rats.
    Gonzalez AM; Sochor M; McLean P
    Diabetes; 1983 May; 32(5):482-5. PubMed ID: 6404681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lens metabolism and cellular effects of aldose reductase.
    McLean P; Gonzalez AM; Sochor M; Hothersall JS
    Diabet Med; 1985 May; 2(3):189-93. PubMed ID: 2952418
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of aldose reductase and its inhibition on sugar cataract formation.
    Kador PF; Akagi Y; Kinoshita JH
    Metabolism; 1986 Apr; 35(4 Suppl 1):15-9. PubMed ID: 3083204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
    Gonzalez AM; Sochor M; Hothersall JS; McLean P
    Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utilization of 13C and 31P nuclear magnetic resonance spectroscopy in the study of the sorbitol pathway and aldose reductase inhibition in intact rabbit lenses.
    Williams WF; Odom JD
    Exp Eye Res; 1987 Jun; 44(6):717-30. PubMed ID: 3115803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldose reductase in diabetic cataracts.
    Kinoshita JH; Kador P; Catiles M
    JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
    [No Abstract]   [Full Text] [Related]  

  • 9. Altered phosphate metabolism in the intact rabbit lens under high glucose conditions and its prevention by an aldose reductase inhibitor.
    González RG; Barnett P; Cheng HM; Chylack LT
    Exp Eye Res; 1984 Nov; 39(5):553-62. PubMed ID: 6440802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the aldose reductase inhibitor sorbinil on the isolated cultured rat lens.
    Yeh LA; Rafford CE; Beyer TA; Hutson NJ
    Metabolism; 1986 Apr; 35(4 Suppl 1):4-9. PubMed ID: 3083208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
    Obrosova IG; Fathallah L
    Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of aldose reductase inhibition in intact lenses by 13C nuclear magnetic resonance spectroscopy.
    Williams WF; Odom JD
    Science; 1986 Jul; 233(4760):223-5. PubMed ID: 3088727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldose reductase, NADPH and NADP+ in normal, galactose-fed and diabetic rat lens.
    Lee SM; Schade SZ; Doughty CC
    Biochim Biophys Acta; 1985 Sep; 841(3):247-53. PubMed ID: 3927985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIH conference. Aldose reductase and complications of diabetes.
    Cogan DG; Kinoshita JH; Kador PF; Robison G; Datilis MB; Cobo LM; Kupfer C
    Ann Intern Med; 1984 Jul; 101(1):82-91. PubMed ID: 6203454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E
    Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
    Beyer-Mears A; Diecke FP; Mistry K; Cruz E
    Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H; Yaginuma T; Mizuno A
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of Alrestatin, an aldose reductase inhibitor, in human diabetic and nondiabetic lenses.
    Chylack LT; Henriques HF; Cheng HM; Tung WH
    Ophthalmology; 1979 Sep; 86(9):1579-85. PubMed ID: 121768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldose reductase in diabetic complications of the eye.
    Kinoshita JH; Fukushi S; Kador P; Merola LO
    Metabolism; 1979 Apr; 28(4 Suppl 1):462-9. PubMed ID: 45423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.